financetom
Business
financetom
/
Business
/
Bandhan Bank Q2 profit down 5% at Rs 920 cr
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Bandhan Bank Q2 profit down 5% at Rs 920 cr
Nov 2, 2020 6:16 AM

Bandhan Bank on Monday reported 5.3 percent decline in net profit at Rs 920 crore for September quarter of the current fiscal year. The bank clocked a net profit of Rs 971.80 crore in the same period of 2019-20.

Total income grew 22 percent to Rs 2,304.90 crore in July-September 2020-21 as against Rs 1,889.30 crore in the year-ago period, Bandhan Bank said in a regulatory filing. Net interest income of the Kolkata-headquartered lender jumped 25.8 percent to Rs 1,923.1 crore during the quarter while the non-interest income grew 6.1 percent to Rs 381.8 crore.

Bandhan Bank said it has reported the highest ever quarterly profit before tax at Rs 1,233 crore during the period under review. Net Interest Margin (annualised) in the quarter fell to 8 percent against 8.2 percent in year-ago period. During the quarter, the bank took accelerated additional provision on standard advances amounting to Rs 300 crore. With this provision and the additional standard assets provision that bank is carrying in micro banking portfolio, the total additional provision in books stands at Rs 2,096 crore, it said.

The bank’s gross non-performing assets fell to 1.2 percent (Rs 874 crore) of gross advances as of September 30, 2020 as against 1.8 percent (Rs 1,064.20 crore) by the year-ago same period. Net NPAs too improved to 0.4 percent (Rs 262.50 crore) from 0.6 percent (Rs 336.90 crore).

”As the moratorium ended on 31st August 2020 coupled with robust rural performance, we have seen an all-round improvement in collection, disbursement and deposits. On deposits front, we have witnessed the best ever quarter whereas on the disbursement front, we are close to pre-COVID-19 level.”

Collections have seen a steady improvement month-on-month and is expected to reach near normal in the next 90 days. We now look forward to accelerate the business in H2FY 21,” Managing Director and CEO Chandra Shekhar Ghosh said. Total Advances grew 19.4 percent to Rs 76,614.6 crore as on September 30, 2020. Total deposits increased 34.4 percent to Rs 66,127.7 crore.

Bandhan Bank stock was trading at Rs 305.50 on BSE, up 5.62 percent from the previous close.

First Published:Nov 2, 2020 3:16 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Germany's Aareal to reap $2.1 bln gain in sale of Aareon to TPG consortium
Germany's Aareal to reap $2.1 bln gain in sale of Aareon to TPG consortium
Jun 24, 2024
FRANKFURT, June 24 (Reuters) - German property lender Aareal Bank will book a gain of around 2 billion euros ($2.14 billion) after it sells its tech unit Aareon to private equity firm TPG and investor CDPQ, it said in announcing the deal on Monday. Aareal, based in Germany but operating globally, said it would only realize the gain later this...
EU can avoid Hungary block on Russian asset plan for Ukraine, Borrell says
EU can avoid Hungary block on Russian asset plan for Ukraine, Borrell says
Jun 24, 2024
June 24 (Reuters) - The European Union has found a way to use proceeds from frozen Russian assets to buy arms for Ukraine despite hold-ups from Hungary, EU foreign policy chief Josep Borrell said on Monday. EU governments agreed in May to use profits from the assets frozen inside the bloc to help Ukraine, with 90% of funds earmarked for...
US FDA approves Roche's drug for a chronic blood disorder (June 21)
US FDA approves Roche's drug for a chronic blood disorder (June 21)
Jun 24, 2024
June 21 (Reuters) - The U.S. Food and Drug Administration on Thursday approved Roche's drug for a chronic blood disorder, the Swiss drugmaker said. The drug crovalimab, branded as PiaSky, is a monthly under-the-skin or intravenous treatment for paroxysmal nocturnal hemoglobinuria (PNH). PNH is a disorder in which red blood cells break apart prematurely. It can cause anemia, fatigue and...
Italy's Eni likely to finalise Enilive stake sale by year-end, CEO says
Italy's Eni likely to finalise Enilive stake sale by year-end, CEO says
Jun 24, 2024
(Corrects third paragraph to show that the 1.3 billion euros is for stakes in Enilive and Novamont, not only Enilive) ROME (Reuters) -Italian energy group Eni expects to complete the sale of a minority stake in its biofuel unit Enilive by the end of 2024, Chief Executive Claudio Descalzi said on Monday. The (sale) plan is in progress, there are still issues that...
Copyright 2023-2026 - www.financetom.com All Rights Reserved